Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Trial Profile

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 19 Mar 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atezolizumab (Primary) ; Tivozanib (Primary)
  • Indications Adenocarcinoma; Advanced breast cancer; Biliary cancer; Cancer; Cholangiocarcinoma; Fallopian tube cancer; Gallbladder cancer; HER2 positive breast cancer; Neuroendocrine carcinoma; Ovarian cancer; Pancreatic cancer; Peritoneal cancer; Prostate cancer; Soft tissue sarcoma; Vulvovaginal cancer
  • Focus Therapeutic Use
  • Acronyms IMMCO-1
  • Most Recent Events

    • 19 Feb 2024 Planned End Date changed from 1 Jun 2024 to 1 Dec 2025.
    • 19 Feb 2024 Planned primary completion date changed from 1 Jan 2024 to 1 Dec 2024.
    • 19 Feb 2024 Status changed from suspended to recruiting.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top